Fernandes kim kenneth

Current Role:

• Associate Executive Director & Chief of Medical Practice and Certification Innovation, American Board of Obstetrics and Gynecology (ABOG)

Previous Positions:

• Director, Gynecologic Oncology, Cedars-Sinai Medical Center
• Professor, Obstetrics & Gynecology, Cedars-Sinai Medical Center
• Fellowship Director, Gynecologic Oncology, University of Alabama at Birmingham

Research Focus Areas:

• Gynecologic Cancer Treatments – Investigating advanced immunotherapy and targeted therapies for ovarian, cervical, and uterine cancers.
• Minimally Invasive & Robotic Surgery – Studying the impact of robotic-assisted gynecologic surgeries on patient outcomes and recovery.
• Clinical Trials – Leading multiple phase I–III clinical trials on new chemotherapy and immunotherapy protocols for gynecologic malignancies.
• Surgical Education & Training – Developing modern OB-GYN and oncology surgical training programs using simulated and hands-on learning techniques.

• Excellence in Gynecologic Oncology Award (2023) – Recognized for outstanding contributions to cancer treatment innovations and research.
•  Best Surgical Educator Award (2022) – Honored by the American College of Obstetricians and Gynecologists (ACOG) for excellence in training the next generation of OB-GYN specialists.
•  Distinguished Researcher in Women’s Cancer (2021) – Awarded for groundbreaking studies in immunotherapy and targeted treatments for gynecologic cancers.

Dr. Kenneth H. Kim is a global leader in gynecologic oncology, dedicated to improving cancer treatments, pioneering surgical advancements, and mentoring future medical professionals. His innovative research and leadership in women’s health continue to shape the future of gynecologic cancer care worldwide.